Gene expression data has been deposited in the Gene Expression Omnibus (GEO) database (accession number GSE44407).

Introduction {#sec001}
============

Epidemiological studies demonstrate that parental obesity increases obesity risk in offspring and suggest an important role of the intrauterine environment owing to stronger associations between maternal than paternal body mass index (BMI) with offspring obesity \[[@pone.0117011.ref001], [@pone.0117011.ref002]\]. Maternal obesity, excess gestational weight gain, high inter-pregnancy BMI and gestational diabetes increase risks of offspring obesity, type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD) and fatty liver \[[@pone.0117011.ref003]--[@pone.0117011.ref005]\]. Environmental and genetic factors mediate the link between parental obesity and increased risk of obesity in offspring \[[@pone.0117011.ref002], [@pone.0117011.ref006]\]; family and twin studies demonstrate heritability of obesity and CVD risk factors \[[@pone.0117011.ref007], [@pone.0117011.ref008]\].

Large-scale genome-wide association studies (GWAS) have consistently revealed the presence of specific genes in metabolic diseases such as type 1 and T2DM \[[@pone.0117011.ref009], [@pone.0117011.ref010]\] and obesity \[[@pone.0117011.ref007], [@pone.0117011.ref011]\]. GWAS on expression traits identified variations regulating gene expression (expression quantitative trait loci; eQTL) and demonstrated that gene expression levels show complex inheritance patterns \[[@pone.0117011.ref012], [@pone.0117011.ref013]\]. Such studies elucidate basic processes of gene regulation and may identify the pathogenesis of prevalent diseases adding information to associations identified by GWAS.

Gene expression levels are greatly affected by genetic and environmental factors \[[@pone.0117011.ref014]\] where gene variations have the potential to attenuate or amplify environmental effects. An adverse intrauterine environment has long been known to contribute to metabolic and cardiovascular diseases \[[@pone.0117011.ref015]\] where differences in expression levels between offspring born under different maternal conditions were reported for specific genes and at genome-wide level \[[@pone.0117011.ref016]--[@pone.0117011.ref019]\]. Several loci associated with specific traits interact with intrauterine environment \[[@pone.0117011.ref020]--[@pone.0117011.ref022]\]. A striking example of such gene-environment interaction is the association of *SIRT1* SNPs with lower prevalence of type 2 diabetes observed in individuals prenatally exposed to famine *in utero* but not in those not exposed to famine.

Bariatric bypass operations improve glucose and lipid metabolism and treat and/or prevent hypertension, dyslipidemia, T2DM and fatty liver disease \[[@pone.0117011.ref023]--[@pone.0117011.ref025]\]. Similar to weight loss \[[@pone.0117011.ref026], [@pone.0117011.ref027]\], bariatric surgery results in changes in gene expression levels \[[@pone.0117011.ref028], [@pone.0117011.ref029]\]. Our studies uniquely demonstrated that offspring born after maternal gastrointestinal bypass surgery (AMS) exhibit lower prevalence of severe obesity, greater insulin sensitivity and improved lipid profiles compared to offspring born before maternal surgery (BMS) \[[@pone.0117011.ref030], [@pone.0117011.ref031]\]. Recently, we demonstrated that these improvements are associated with differences in gene expression and methylation of genes involved in diabetes and immune and inflammatory pathways \[[@pone.0117011.ref017], [@pone.0117011.ref032]\].

In order to further explore the role of the intrauterine environment in the determination of offspring phenotype and to provide molecular mechanisms explaining changes in cardiometabolic risk markers of AMS vs. BMS offspring, we studied the combined influence of maternal surgical status and offspring gene variations on offspring gene expression levels.

Materials and Methods {#sec002}
=====================

Subjects {#sec002a}
--------

Women from Quebec City and surrounding areas (administrative regions of Capitale-Nationale, Mauricie and Chaudière-Appalaches) who had given birth before and after biliopancreatic diversion with duodenal switch \[[@pone.0117011.ref025]\] for severe obesity were eligible. We recruited a subset of 19 unrelated mothers aged 34--51 years having offspring aged 2--23 years, 22 born before and 23 after maternal operations. Between July and October 2010 mothers and offspring visited the Quebec Heart and Lung Institute (Quebec City, Quebec, Canada) or a regional hospital for clinical evaluation and blood sampling. There were 15 mothers with siblings born before and after surgery (21 BMS and 18 AMS), one with BMS offspring only (1 BMS) and 3 mothers with only AMS offspring (5 AMS).

Maternal pre-surgical data were obtained from medical records. At the office visit weight and percent body fat were determined for individuals aged 6 years or more (BMS, N = 21; AMS, N = 15) using bioelectric impedance analysis (Tanita; Arlington Heights, IL). Height and resting systolic (SBP) and diastolic (DBP) blood pressure were obtained using standardized procedures. BMI was calculated for mothers and adults and BMI percentiles for children were obtained from the National Health and Nutrition Examination Survey 2000 chart \[[@pone.0117011.ref033]\]. BMI Z-score was calculated for children using charts from the Centers for Disease Control and Prevention \[[@pone.0117011.ref034]\]. Fasting whole blood samples were collected from an antecubital vein into tubes containing EDTA and PAXgene Blood RNA collection tubes (Qiagen, Valencia, CA, USA). Plasma lipid, glucose and insulin concentrations were measured as previously described \[[@pone.0117011.ref035]\]. Lipid and glucose levels values from 3 AMS non-fasting offspring were excluded. The homeostatic model assessment of insulin resistance (HOMA-IR) index was calculated as fasting glucose x insulin/22.5. Levels of high-sensitivity C-reactive protein (CRP) were measured with a BN ProSpec nephelometer (Siemens Canada Limited, Oakville, Ontario, Canada) \[[@pone.0117011.ref036]\]. CRP values under the detection limit (\< 0.17 mg/L) were arbitrarily set at detection limit.

Ethics Statement {#sec002b}
----------------

This study was approved by the Quebec Heart and Lung Institute Ethics Committee. Written informed consent was obtained from mothers and adult offspring and assent from minor offspring were obtained from mothers.

Gene expression analysis {#sec002c}
------------------------

Gene expression levels of the 45 offspring analyzed here were obtained from previous studies from our group evaluating differences in gene expression and methylation of genes involved in diabetes, immune and inflammatory pathways \[[@pone.0117011.ref017], [@pone.0117011.ref032]\]. Briefly, total RNA was isolated and purified from offspring whole blood using PAXgene Blood RNA Kit (Qiagen). The quality and integrity of the purified RNA was assessed using both the NanoDrop (Thermo Scientific, Wilmington, DE, USA) and the 2100 Bioanalyzer (Agilent Technologies, Cedar Creek, TX, USA). Expression levels were measured using the HumanHT-12 v4 Expression BeadChip (Illumina Inc., San Diego, CA) with 250 ng of total RNA and processed at the McGill University and Genome Quebec Innovation Centre (Montreal, Canada). Expression data were visualized and analyzed using the FlexArray software \[[@pone.0117011.ref037]\] (version 1.6) and the lumi R package was used for expression data analysis and normalization. To be considered as expressed, a probe had to show a detection p-value ≤ 0.05 in at least 25% of samples of a group. Among the 47,323 probes on the microarray, 16,060 (33.9%) showed significant gene expression in blood and were used as dependent expression phenotypes (expression traits) for analysis of interactions between offspring gene variations and maternal obesity status (GEO accession number GSE44407).

DNA extraction and genome-wide genotyping {#sec002d}
-----------------------------------------

Genomic DNA was isolated from offspring blood buffy coat using the GenElute Blood Genomic DNA kit (Sigma, St Louis, MO, USA). Quantification and verification of DNA quality were conducted via both NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and PicoGreen DNA methods. Genotyping was performed at McGill University and Genome Quebec Innovation Centre (Montreal, Canada) using Illumina HumanOmni-5-Quad BeadChip (Illumina Inc., San Diego, CA), according to the manufacturer's instructions. Each HumanOmni-5-Quad BeadChip contained 4,301,331 markers.

SNPs and sample quality control {#sec002e}
-------------------------------

Calculations of allele frequencies and tests of SNP data for Hardy-Weinberg equilibrium (HWE) were performed using PLINK \[[@pone.0117011.ref038]\] (version 1.07). Standard quality control exclusion criteria for the SNPs were used: call rate \< 95%, genotype distribution deviating from Hardy-Weinberg Equilibrium (p-values less than 10^--7^) and monomorphic SNPs or those with a minor allele frequency (MAF) \< 0.01 \[[@pone.0117011.ref039]\]. A total of 1,751,034 SNPs were excluded leaving 2,550,297 SNPs for statistical analyses. All samples were tested for call rate (\> 90%), ethnicity (Caucasian; HapMap) and gender mismatch based on genotyping data. No subjects were excluded: all 45 samples were used in further analysis.

Statistical analysis {#sec002f}
--------------------

Anthropometric and clinical data were expressed as mean ± SD. Maternal treatment effect on anthropometric-, blood pressure-, lipid profile- and glucose-related variables was assessed using a within-subject, paired t-test. Differences between BMS and AMS offspring were tested using analysis of variance (general linear model, type III sum of squares) and adjusted for the effects of sex and puberty. BMI percentile and BMI Z-score being obtained from age- and sex-specific charts, no further adjustments for age and sex were made to test for differences between BMS and AMS offspring for those adiposity measurements. Severe obesity in offspring was defined as BMI percentile \> 98% and Z-score \> 3. Transformations were applied to non-normally distributed variables (log10 transformed for insulin and HOMA-IR; negative inverse transformed for C-reactive protein). In the absence of Tanner scores, we arbitrarily defined puberty as 12 years for female and 14 years for male offspring based on Canadian sex-specific probabilities of having entered puberty \[[@pone.0117011.ref040]\]. Differences in severe obesity between BMS and AMS offspring were evaluated using BMI percentile and BMI Z-score and tested using Fisher's exact test. P-values for CRP were adjusted for the effects of sex, puberty and BMI percentile. Statistical analyses were done using the SAS software version 9.2 (SAS Institute Inc). Statistical significance was defined as p ≤ 0.05. Interactions between offspring gene variations and maternal surgical status were tested on offspring gene expression levels in whole blood using PLINK. Differences in regression slopes obtained from additive model were then tested between BMS and AMS offspring. Bonferroni correction was applied to correct for multiple testing of offspring gene variation x environment interactions thus leading to a p-value cutoff of p ≤ 1.22x10--^12^ (as calculated with 0.05/ (2,550,297 SNPs x 16,060 transcripts)) to claim statistical significance. Linkage disequilibrium (LD; r^2^) between SNPs demonstrating significant interactions was calculated using Haploview \[[@pone.0117011.ref041]\] to assess the number of independent (non-linked) SNPs. The tagger algorithm implemented in Haploview was used to identify tag SNPs among the significant polymorphisms (r^2^ threshold = 0.8).

Gene functions and pathways analysis {#sec002g}
------------------------------------

Two independent function and pathway analysis tools were employed to identify potentially enriched functions and overrepresented pathways from the list of transcripts demonstrating significant interactions, namely the Database for Annotation, Visualization, and Integrated Discovery (DAVID; <http://david.abcc.ncifcrf.gov>) bioinformatics resources \[[@pone.0117011.ref042], [@pone.0117011.ref043]\] and Ingenuity Pathway Analysis (IPA). DAVID provided annotation for the list of transcripts and computed annotation term enrichment to highlight the most relevant functions from the list of transcripts. Similarly, IPA classified each transcript from this list according to function and pathway. Using a right-tailed Fisher's exact test, IPA measured the likelihood that transcripts from the list participate in each function/pathway solely due to chance and calculated p-values. Enriched functions and overrepresented pathways were then obtained from transcripts showing interactions.

Results {#sec003}
=======

Characteristics of 19 mothers and their 45 offspring {#sec003a}
----------------------------------------------------

Mean postoperative follow-up for the mothers after bilio-pancreatic diversion surgery was 12 years 7 months (range: 4 years 11 months to 22 years 4 months). Preoperative weight was 121.6 ± 18.7 kg (BMI = 45.1 ± 7.4) and 74.9 ± 12.2 kg (BMI = 27.6 ± 4.9) at follow-up, a mean loss of 46.7 kg, associated with significant, clinically important improvements in fasting plasma lipids (p ≤ 0.005 for TG, HDL-C, LDL-C, total-C and total-C/HDL-C ratio), glucose levels (5.81 ± 2.41 vs. 4.68 ± 0.32; p = 0.048) and blood pressure (SBP and DBP; p ≤ 0.001) were observed ([S1 Table](#pone.0117011.s002){ref-type="supplementary-material"}).

Offspring ages varied between 2 years 8 months and 23 years 9 months, with similar sex distributions in the two groups (41% male in BMS vs. 43% in AMS; [Table 1](#pone.0117011.t001){ref-type="table"}). BMS offspring were born 3 years 4 months (40.2 ± 28.0 months) before and AMS 3 years 9 months (44.9 ± 26.6 months) after maternal surgery. BMS offspring were older than AMS at follow-up (14.5 ± 5.7 vs. 9.0 ± 5.0 years; p = 0.001; BMS range: 5 years 9 months to 23 years 9 months; AMS range: 2 years 8 months to 19 years 6 months). Severe obesity was less prevalent in AMS using BMI percentile (p = 0.01) or BMI Z-score (p = 0.02). Adjusting for sex and puberty, AMS offspring exhibited trends toward lower fasting insulin levels and HOMA-IR index, and lower diastolic blood pressure (p \< 0.10 for all).

10.1371/journal.pone.0117011.t001

###### Offspring characteristics.

![](pone.0117011.t001){#pone.0117011.t001g}

                                                                     **BMS**         **AMS**        **p-values** [^1^](#t001fn001){ref-type="table-fn"}
  ------------------------------------------------------------------ --------------- -------------- -----------------------------------------------------
  N (males)                                                          22 (9)          23 (10)        
  Age (years)                                                        14.5 ± 5.7      9.0 ± 5.0      0.001
  [Anthropometric data]{.ul}                                                                        
   Fat percent[^2^](#t001fn002){ref-type="table-fn"}                 29.6 ± 14.4     22.7 ± 10.3    0.28
   BMI percentile                                                    68.7 ± 41.5     69.7 ± 30.9    0.93
   BMI Z-score[^3^](#t001fn003){ref-type="table-fn"}                 1.93 ± 2.18     0.90 ± 1.48    0.08
   Severe obesity                                                                                   
    BMI percentile \> 98% (N)                                        11              3              0.01
    BMI Z-score \> 3 (N)                                             7               1              0.02
  [Blood pressure]{.ul}                                                                             
   SBP (mm Hg)                                                       110.5 ± 14.9    96.7 ± 14.8    0.13
   DBP (mm Hg)                                                       64.3 ± 10.5     52.8 ± 13.2    0.06
  [Lipid profile]{.ul} [^4^](#t001fn004){ref-type="table-fn"}                                       
   TG (mmol/l)                                                       1.03 ± 0.44     0.81 ± 0.38    0.29
   LDL-C (mmol/l)                                                    2.66 ± 0.56     2.53 ± 0.59    0.67
   HDL-C (mmol/l)                                                    1.30 ± 0.31     1.30 ± 0.26    0.76
   Total-C (mmol/l)                                                  4.44 ± 0.67     4.20 ± 0.59    0.39
   Total-C / HDL-C                                                   3.58 ± 0.97     3.37 ± 0.87    0.76
  [Glucose metabolism]{.ul} [^4^](#t001fn004){ref-type="table-fn"}                                  
   Fasting glucose (mmol/l)                                          4.94 ± 0.44     4.77 ± 0.37    0.54
   Insulin (μU/ml)                                                   19.98 ± 12.54   11.45 ± 7.50   0.06
   Homa-IR                                                           4.55 ± 3.34     2.49 ± 1.74    0.08
  CRP (mg/L)[^5^](#t001fn005){ref-type="table-fn"}                   5.54 ± 8.34     1.54 ± 3.69    0.12

Values are presented as mean ± SD.

^1^ P-values adjusted for sex and puberty except for BMI percentile and BMI Z-score and obtained from comparison of all BMS (N = 22) and AMS (N = 23) offspring.

^2^ Fat percent at 6 years or more (BMS, N = 21; AMS, N = 15).

^3^ BMS, N = 19; AMS, N = 22.

^4^ BMS, N = 22; AMS, N = 20.

^5^ P-values for CRP were adjusted for the effects of sex, puberty and BMI percentile. Abbreviations: BMS, before maternal surgery; AMS, after maternal surgery; BMI, body mass index; SBP and DBP, systolic diastolic and systolic blood pressure; TG, triglycerides; LDL-C; low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Total-C, total cholesterol; CRP, C-reactive protein; SD, standard deviation.

Interactions effects between offspring gene variations and maternal surgical status {#sec003b}
-----------------------------------------------------------------------------------

Testing interactions between 2,550,297 offspring SNPs and maternal status on 16,060 expression phenotypes in offspring demonstrated 102,129 interactions reaching statistical significance (representing 0.00025% of all tests; p ≤ 1.22x10^--12^). The top significant interactions are shown in [Table 2](#pone.0117011.t002){ref-type="table"}. These represent 48,156 unique SNPs (1.9% of the SNPs tested), 33.6% (16,184) of which demonstrated statistically significant interactions for multiple transcripts. Identified SNPs were mainly in intergenic regions (61%) while intronic, exonic and untranslated region SNPs represented a minority (35%, 2% and 2% respectively). SNP rs35447805 (kgp1360358) located at chr8:85131756 within the *RALYL* gene (NM_001100391) demonstrated the most statistically significant interaction with treatment for expression level of *SEPT4* (NM_080415) and *IFI35* (NM_005533), both located on chromosome 17 ([Table 2](#pone.0117011.t002){ref-type="table"}). As an example, interaction effect for rs35447805 on *SEPT4* expression levels manifested in a 2.5 fold increase in expression for AMS heterozygous carriers and slight decrease (0.9 fold) for BMS heterozygous carriers ([S2 Table](#pone.0117011.s003){ref-type="supplementary-material"}). SNPs located in the interferon (alpha, beta and omega) receptor 1 (*IFNAR1*)---interleukin 10 receptor, beta (*IL10RB*) gene region and those near transmembrane protein, adipocyte associated 1 (GPR175, also known as TPRA1), BARX homeobox 2 (*BARX2*) transcription factor and heparan sulfate (glucosamine) 3-O-sulfotransferase 4 (*HS3ST4*) demonstrated several significant interactions ([S3 Table](#pone.0117011.s004){ref-type="supplementary-material"}).

10.1371/journal.pone.0117011.t002

###### Most significant SNP-by-maternal treatment interactions.

![](pone.0117011.t002){#pone.0117011.t002g}

  **SNP**                                           **Transcript**                                                                                        
  ------------------------------------------------- ------------------------------------------------- ---- ----------- -------------- -------------- ---- ---------------
  kgp11796917                                       rs146836802                                       14   30685942    NM_194323      OTOF           2    1.09x10^--57^
  kgp30566776                                       rs73229805                                        X    67014865    NM_001010927   TIAM2          6    3.53x10^--45^
  kgp8430951                                        rs78240927                                        6    163766098   NM_001100422   SPATS2L        2    2.37x10^--37^
  kgp11155608                                       rs12059564                                        1    159000779   NM_015913      TXNDC12        1    7.81x10^--32^
  kgp1360358                                        rs35447805                                        8    85131756    NM_080415      SEPT4          17   4.70x10^--30^
  kgp6389054                                        rs78957751                                        16   34886264    NM_001006630   CHRM2          7    4.14x10^--27^
  rs4764191                                         rs4764191                                         12   15560196    NM_001032295   SERPING1       11   4.43x10^--27^
  kgp11709552                                       rs62227091                                        22   47811418    NM_001011724   HNRNPA1L2      13   3.15x10^--26^
  kgp30620929                                       rs140547157                                       X    27936207    XM_945614      PMS2L1         7    3.32x10^--26^
  kgp11042611                                       rs79592528                                        3    122772698   XM_938400      LOC142937      10   3.97x10^--26^
  kgp8787288                                        rs940676                                          2    121235234   NM_003733      OASL           12   8.00x10^--25^
  kgp4545030                                        rs78211484                                        12   59934484    CK299576       HS.528210      3    5.46x10^--24^
  kgp18518                                          rs17757256                                        2    19650629    NM_001007524   F8A3           X    1.19x10^--23^
  kgp2333358                                        rs1461092                                         12   41556961    NM_005419      STAT2          12   4.89x10^--23^
  kgp8581526                                        rs36117773                                        5    11939359    NM_025126      RNF34          12   1.15x10^--22^
  kgp494941                                         rs79270474                                        12   12338554    NM_002535      OAS2           12   1.59x10^--22^
  kgp6448962                                        rs57573303                                        9    28322259    NM_001012978   BEX5           X    5.84x10^--22^
  rs3803712                                         rs3803712                                         16   26074500    NM_001712      CEACAM1        19   7.21x10^--22^
  kgp36317                                          rs2247335                                         6    106992592   NM_001007234   ERCC8          5    8.83x10^--22^
  kgp4630305                                        rs59557850                                        8    78148122    NM_003728      UNC5C          4    1.10x10^--21^
  rs9655226                                         rs9655226                                         7    22598742    NM_170695      TGIF1          18   3.07x10^--21^
  kgp10592712                                       rs73063011                                        19   52338183    NM_024032      C17ORF53       17   8.71x10^--21^
  kgp237322                                         rs539822                                          5    176310164   XM_001721497   LOC100132457   2    1.02x10^--20^
  rs11053624                                        rs11053624                                        12   10283711    NM_015589      SAMD4A         14   1.51x10^--20^
  kgp11540460                                       rs144298037                                       6    45434746    NM_001004349   FLJ45422       6    1.56x10^--20^
  kgp11526978                                       rs4711691                                         6    12404895    NM_014453      CHMP2A         19   3.55x10^--20^
  kgp11514400                                       rs35833993                                        6    165457847   NM_006918      SC5D           11   5.65x10^--20^
  kgp3001132                                        rs9606166                                         22   19811720    NM_006704      SUGT1          13   6.90x10^--20^
  kgp9305036                                        rs943009                                          6    11243891    NR_002940      LRRC37A4       17   1.59x10^--19^
  kgp8789955                                        rs62576233                                        9    84337468    NM_005792      MPHOSPH6       16   1.63x10^--19^
  kgp1173427                                        rs61733660                                        6    151148947   XM_925998      SRA1           5    1.82x10^--19^
  rs2968402[^5^](#t002fn005){ref-type="table-fn"}   rs2968402[^4^](#t002fn004){ref-type="table-fn"}   16   21947480    NM_014598      SOCS7          17   3.16x10^--19^
  kgp12304307                                       rs13298711                                        9    83820909    NM_002256      KISS1          1    3.45x10^--19^
  rs11636802                                        rs11636802                                        15   56775597    DA276856       HS.576243      1    3.53x10^--19^
  kgp12481432                                       rs4407201                                         2    130522894   NM_016134      CPQ            8    4.88x10^--19^
  kgp31122632                                       rs138131809                                       X    116143012   NR_024524      LOC100129055   10   6.25x10^--19^
  rs7149078                                         rs7149078                                         14   32844576    CD369504       HS.540642      16   6.57x10^--19^
  kgp4554682                                        rs1108962                                         4    100663492   AI274046       HS.555512      14   8.86x10^--19^
  kgp8947215                                        rs73030956                                        12   1675847     NM_018271      FLJ10916       2    9.40x10^--19^
  kgp7059559                                        rs1831464                                         13   92902619    NM_019062      RNF186         1    9.67x10^--19^
  kgp4609959                                        rs13284671                                        9    824742      NM_002720      PPP4C          16   1.02x10^--18^
  kgp2913569                                        rs36067040                                        1    224238495   NM_001017977   DCAF6          1    1.32x10^--18^
  kgp1360358                                        rs35447805                                        8    85131756    NM_005533      IFI35          17   1.67x10^--18^
  kgp6643156                                        rs79321471                                        14   101498881   NM_017831      RNF125         18   1.81x10^--18^
  kgp619464                                         rs4292995                                         1    30738298    NM_022148      CRLF2          Y    2.36x10^--18^
  rs6074541                                         rs6074541                                         20   12978517    NM_006286      TFDP2          3    2.87x10^--18^
  kgp12299095                                       rs35007051                                        2    188415764   NM_002164      IDO1           8    3.76x10^--18^
  kgp12307971                                       rs76107005                                        10   85534815    NM_002201      ISG20          15   4.36x10^--18^
  kgp10871570                                       rs115462216                                       21   22882926    U43604         HS.550193      5    4.78x10^--18^
  rs3025651                                         rs3025651                                         6    29539914    NM_003646      DGKZ           11   6.03x10^--18^

List of the top 50 significant interactions. Regulated transcripts and respective p-values are shown.

SNP with the most significant association obtained from comparison of all BMS (N = 22) and AMS (N = 23) offspring was shown for each transcript.

^1^ SNP ID as defined by Illumina HumanOmni-5-Quad BeadChip annotation.

^2^ Genome build 37.

^3^ RefSeq or UniGene nomenclature.

^4^ P-values for differences between regression slopes (BMS vs. AMS) obtained from an additive model.

^5^ SNP mapped at two locations (chr16:21947480 and chr16:29119905). Abbreviations: SNP, single nucleotide polymorphism; Chr, chromosome.

Statistically significant offspring SNP-by-maternal surgical status interactions identified for the 48,156 unique SNPs involved 525 unique transcripts (3.3%) thus implying that a single transcript might be under multiple genetic constraints. Indeed, 375 of these 525 unique transcripts (71.4%) demonstrated multiple (≥2) significant interactions. The most highly represented transcripts from significant interactions are shown in [Table 3](#pone.0117011.t003){ref-type="table"}, including transcripts encoding genes involved in regulation of gene expression *per se*, immune and inflammatory responses and lipid biosynthesis from which examples for *STAT2* (NM_005419), *IFI35* (NM_005533) and *DGKZ* (NM_003646) are shown in [S1 Fig.](#pone.0117011.s001){ref-type="supplementary-material"} LD was found between SNPs, resulting in multiple significant interactions with an identical transcript: 14,676 interaction tagging SNPs (tSNPs) were identified among the 48,156 unique SNPs showing significant interactions. Limiting analysis to these tSNPs led to the identification of 56.2% of the transcripts showing multiple statistically significant interactions.

10.1371/journal.pone.0117011.t003

###### Most represented transcripts from the list of significant interactions.

![](pone.0117011.t003){#pone.0117011.t003g}

  **Transcript[^1^](#t003fn001){ref-type="table-fn"}**   **Accession**   **Significant interactions (N)**   **Most significant p-value[^2^](#t003fn002){ref-type="table-fn"}**
  ------------------------------------------------------ --------------- ---------------------------------- --------------------------------------------------------------------
  SEPT4                                                  NM_080415       8492                               4.70x10^--30^
  OTOF                                                   NM_194323       8473                               1.09x10^--57^
  SPATS2L                                                NM_001100422    8465                               2.37x10^--37^
  TXNDC12                                                NM_015913       8172                               7.81x10^--32^
  LOC142937                                              XM_938400       6690                               3.97x10^--26^
  HNRNPA1L2                                              NM_001011724    6151                               3.15x10^--26^
  HS.528210                                              CK299576        5804                               5.46x10^--24^
  TIAM2                                                  NM_001010927    5204                               3.53x10^--45^
  OAS2                                                   NM_002535       4396                               1.59x10^--22^
  SERPING1                                               NM_001032295    4168                               4.43x10^--27^
  OASL                                                   NM_003733       2964                               8.00x10^--25^
  HS.550193                                              U43604          2886                               4.78x10^--18^
  FLJ45422                                               NM_001004349    2659                               1.56x10^--20^
  TCP1                                                   NM_030752       1823                               3.15x10^--17^
  RNF125                                                 NM_017831       1762                               1.81x10^--18^
  CEACAM1                                                NM_001712       1728                               7.21x10^--22^
  SRA1                                                   XM_925998       1545                               1.82x10^--19^
  IFI35                                                  NM_005533       1474                               1.67x10^--18^
  STAT2                                                  NM_005419       1371                               4.89x10^--23^
  HS.391327                                              BX110374        1352                               1.39x10^--16^
  PMS2L1                                                 XM_945614       1080                               3.32x10^--26^
  SAMD4A                                                 NM_015589       949                                1.51x10^--20^
  DGKZ                                                   NM_003646       840                                6.03x10^--18^
  ISG20                                                  NM_002201       798                                4.36x10^--18^
  LOC649009                                              XM_941706       701                                2.41x10^--17^
  HS.553068                                              BX103476        533                                1.32x10^--15^
  F8A3                                                   NM_001007524    502                                1.19x10^--23^
  BEX5                                                   NM_001012978    475                                5.84x10^--22^
  LRRC37A4                                               NR_002940       462                                1.59x10^--19^
  LOC401525                                              XM_376869       447                                8.58x10^--18^
  LOC649143                                              XM_944822       403                                6.06x10^--18^
  SUGT1                                                  NM_006704       400                                6.90x10^--20^
  FANCA                                                  NM_000135       366                                6.50x10^--18^
  PPP4C                                                  NM_002720       321                                1.02x10^--18^
  GOLM1                                                  NM_177937       317                                5.85x10^--17^
  PIGC                                                   NM_153747       295                                4.51x10^--17^
  TAPBP                                                  NM_172209       274                                1.56x10^--16^
  ATF3                                                   NM_001040619    216                                3.66x10^--17^
  RNF34                                                  NM_025126       194                                1.15x10^--22^
  HS.539736                                              AI979341        192                                9.90x10^--18^
  LOC100132347                                           XM_001713703    186                                2.06x10^--15^
  LOC100132457                                           XM_001721497    168                                1.02x10^--20^
  CPQ                                                    NM_016134       165                                4.88x10^--19^
  UBXD7                                                  XM_936412       146                                4.18x10^--15^
  FAT3                                                   XM_926199       145                                1.15x10^--15^
  RNF186                                                 NM_019062       139                                9.67x10^--19^
  ZBP1                                                   NM_030776       134                                1.16x10^--14^
  OPRL1                                                  NM_000913       131                                9.08x10^--15^
  LOC645253                                              XM_944197       127                                1.79x10^--15^
  HIST1H4H                                               NM_003543       125                                7.54x10^--16^

^1^ RefSeq or UniGene nomenclature.

^2^ P-values for differences between regression slopes (BMS vs. AMS) obtained from an additive model. Abbreviation: N, number.

Gene functions and pathways {#sec003c}
---------------------------

Clustering of the 525 transcripts showing significant interactions based on ontology using DAVID identified 5 over-represented functional categories (-log group enrichment score \> 1.30; p-value for group enrichment score \< 0.05): 1) transcription, 2) metabolic process, 3) guanine nucleotide exchange factor, 4) death/ZU5 domain and 5) zinc finger domain ([S4 Table](#pone.0117011.s005){ref-type="supplementary-material"}). IPA analysis revealed infectious disease, inflammatory response, gene expression, and cellular growth and proliferation among the over-represented functional categories from the list of transcripts demonstrating statistically significant interactions, thus highlighting transcription and cellular metabolism functions using both function analysis tools. Similarly, IPA revealed 18 pathways enriched for these transcripts, including 12 related to cellular stress and signaling, immune response and inflammation, and growth, proliferation and development. Importantly, DNA Double-Strand Break Repair by Homologous Recombination was the most overrepresented pathway (p = 0.001) and carbohydrate and lipid biosynthesis/degradation pathways were also identified ([Fig. 1](#pone.0117011.g001){ref-type="fig"}).

![Pathways enriched from transcripts demonstrating significant interactions.\
The number of submitted transcripts in each pathway is reported in histogram bars. Histogram bars for pathways related to cellular stress and signaling (black), immune response and inflammation (dark grey), and growth, proliferation and development (light grey) are highlighted. Unrelated pathways are shown in white.](pone.0117011.g001){#pone.0117011.g001}

Discussion {#sec004}
==========

In a unique offspring cohort born discordant for maternal biliopancreatic bypass surgery affecting maternal metabolic fitness we extend observations that an adverse dysmetabolic intrauterine environment is associated with subsequent obesity and cardiometabolic risk \[[@pone.0117011.ref030], [@pone.0117011.ref031]\] related to gene expression levels \[[@pone.0117011.ref016], [@pone.0117011.ref018], [@pone.0117011.ref019]\]. Using a cohort in which gene expression and methylation levels were previously evaluated in regards to metabolic differences between BMS and AMS offspring \[[@pone.0117011.ref017], [@pone.0117011.ref032]\], the current study focusing on a different aspect (gene-environment interactions) demonstrated modulatory effects of maternal fitness on the association between genotype and gene expression in offspring. In this study we tested gene expression levels (expression traits) for interactions between offspring SNPs and maternal treatment. By analyzing the offspring genotypes and gene expression at the genome-wide level combined with the impact of maternal status, we provide an objective insight into the relation between maternal status and offspring cardiometabolic risk profile and have the potential to elucidate the functional basis of known associations identified previously.

Overlapping SNPs identified here with those previously associated with specific phenotypes and metabolic variables in GWAS has the potential to elucidate mechanisms for previously reported associations. Systematic comparison of SNPs and regulated transcripts with results from GWAS was then conducted. Our top interactions ([Table 2](#pone.0117011.t002){ref-type="table"}) identified SNP rs57573303 in the gene *LINGO2* and SNP rs3803712 located in *HS3ST4*. The former was associated with *BEX5* expression levels, a brain expressed X-linked gene family member regulating differentiation of dopamine neurons involved in food reward signaling \[[@pone.0117011.ref044]\]. The latter we found was associated with *CEACAM1* gene expression levels encoding a cell-cell adhesion molecule involved in differentiation, apoptosis and modulation of innate and adaptive immune response consistent with decreased liver *CEACAM1* expression reported in severely obese patients \[[@pone.0117011.ref045]\]. In regards to the interaction identified here, increased *CEACAM1* expression was observed in heterozygous AMS offspring while BMS rare allele carriers demonstrated lower *CEACAM1* expression. SNPs in *LINGO2* and *HS3ST4* were previously found to be associated with children BMI z-score and % fat mass, respectively \[[@pone.0117011.ref011]\]. Associations between rs10968576, also in *LINGO2*, and fasting plasma cholesterol levels and BMI were found in different populations \[[@pone.0117011.ref046], [@pone.0117011.ref047]\]. We identify here rs115462216 SNP (kgp10871570) in *NCAM2* for which rs11088859 has been associated with waist circumference \[[@pone.0117011.ref048]\]. In addition, the presence of neurological (*ERCC8*, *KISS1*, *IDO1*, *OTOF*, *SEPT4*, *SERPING1*, *SOCS7*, *STAT2*, *TGIF1*, *TIAM2*) and endocrine system development (*CHRM2*, *SC5D*, *SOCS7*) genes among the regulated transcripts ([Table 2](#pone.0117011.t002){ref-type="table"}) suggest a mechanistic role in offspring programming under varying maternal conditions \[[@pone.0117011.ref019], [@pone.0117011.ref049]\]. Taken together, the identification of SNPs located in genes previously reported by others to be associated with obesity traits support our results and is consistent with studies showing that SNPs associated with complex traits are more likely to be eQTLs \[[@pone.0117011.ref050], [@pone.0117011.ref051]\].

The limited number of transcripts for which we found offspring gene variation-by-maternal status interactions and the large number of SNPs suggest that single transcripts may be under multiple genetic constraints, coherent with previous studies conducted on larger cohorts \[[@pone.0117011.ref052]--[@pone.0117011.ref054]\]. Among the numerous SNPs we identified with significant interactions, many were specifically associated with the inflammatory, insulin-resistant, dysmetabolic diathesis of diabesity such as SNPs in the *IFNAR1---IL10RB* gene region forming the class II cytokine receptor gene cluster ([S3 Table](#pone.0117011.s004){ref-type="supplementary-material"}). Those genes involved in IL10-induced signal transductions were associated with inflammatory diseases and ischemic stroke with hypertension \[[@pone.0117011.ref055]--[@pone.0117011.ref057]\]. We also observed significant interactions for SNPs located near the *GPR175* (*TPRA1*) gene, expression level of which was previously demonstrated to be associated with plasma lipid levels \[[@pone.0117011.ref058]\]. Furthermore, we found interactions of SNPs near *BARX2*, a member of the homeobox transcription factor family known to influence cellular processes controlling cell adhesion and remodeling actin cytoskeleton. Others previously found such associations with T2DM and end-stage renal disease \[[@pone.0117011.ref059]\].

Gene function analysis conducted with two independent tools highlighted genes related to transcription and cellular metabolism. Combined with other overrepresented functional categories (guanine nucleotide exchange factor, death/ZU5 domain, zinc finger domain), these results suggested some potential effects of maternal metabolic fitness on offspring at both the cellular and transcriptional levels. Our pathway analysis also identified pathways related to cellular growth, proliferation and development, stress and signaling as well as carbohydrate and lipid metabolism similar to others' findings. Global gene expression analysis of amniotic fluid cell-free fetal RNA identified lipid (*apolipoprotein D*) and transcriptional regulators (*FOS* and *STAT3*) as well as apoptotic cell death-related genes among differentially expressed genes between fetuses of obese vs. lean pregnant women \[[@pone.0117011.ref016]\]. In conjunction with influences of maternal obesity before conception reported on gene expression profiles of rat embryos, genes related to cell cycle, carbohydrate metabolism, DNA repair and transcriptional regulator were altered \[[@pone.0117011.ref060]\]. These results strengthen our observations pertaining to an overrepresentation of cellular processes (cellular growth, proliferation and development), carbohydrate and lipid metabolism pathways identified. The study on rat embryos \[[@pone.0117011.ref060]\] also supports overrepresentation of immune response and inflammatory genes as well as DNA double-strand break repair-related genes among transcripts with significant interactions. Similar to changes in expression previously observed in obese patients early after having undergone weight loss or bariatric surgery \[[@pone.0117011.ref026], [@pone.0117011.ref027], [@pone.0117011.ref029]\], we found that inflammation-related transcripts were overrepresented. Globally, overrepresentation of cellular signaling, carbohydrate metabolism and inflammatory pathways identified here from the list of transcripts showing significant offspring gene variations by maternal surgical status interactions are in line with previous results from our group comparing BMS and AMS offspring at gene methylation and expression levels \[[@pone.0117011.ref017], [@pone.0117011.ref032]\]. In addition, our results are consonant with murine studies showing effects of maternal gestational obesity and high-fat diet on offspring with differences in gene expression levels for genes related to inflammation and glucose homeostasis \[[@pone.0117011.ref061], [@pone.0117011.ref062]\] and for pathways related to cellular stress, signaling, growth, proliferation, development and regulation of lipogenic pathways \[[@pone.0117011.ref063]\] of significant pathogenic importance for the dysmetabolic diathesis of diabesity. Our pathway analysis demonstrated involvement of carbohydrate and lipid metabolism pathways, in agreement with results from maternal weight loss studies in sheep demonstrating an impact on insulin signaling, glucose transport and glycogen synthesis pathways in offspring' skeletal muscle \[[@pone.0117011.ref064]\] as well as with previous studies demonstrating gene-by-maternal diet interactions in offspring \[[@pone.0117011.ref021], [@pone.0117011.ref065]\].

Some of the modulating effects of gestational metabolic fitness may be confounded. Young age of the offspring limits the potential contribution of different postnatal environments. However, it does not allow extrapolation over the life span stretching into mature adulthood when most pathology emerges through the cumulative effects of environmental exposures. Nevertheless, the preponderance of literature on developmental origins of adult disease, specifically for cardio-metabolic outcomes related to our findings demonstrates durability of effects over the life-span \[[@pone.0117011.ref015]\]. The rarity of gastrointestinal biliopancreatic bypass surgery, low pregnancy rates before and after maternal surgery, constraints of study design and the exclusive nature of the molecular analyses all limited the size of our offspring population. The size of the study sample limited the number of adjustments made to correct for confounding factors relating to offspring and maternal condition during pregnancy (breastfeeding, smoking, etc.). Adjustments for confounding factors were thus limited to sex and puberty. Although metabolic parameters in the offspring cohorts were not statistically significantly different owing to sample size, the differences were clinically significant particularly for insulin resistance, dyslipidemia and CRP. Studies from our group conducted on larger cohorts have previously demonstrated robust group differences between BMS and AMS offspring \[[@pone.0117011.ref030], [@pone.0117011.ref031]\]. Our gene analyses were performed on blood, more convenient to obtain and to justify sampling than other tissues in healthy juvenile offspring. We and others have reported partial inter-tissue correlations \[[@pone.0117011.ref054], [@pone.0117011.ref066]--[@pone.0117011.ref068]\]. The multicellular nature of blood constitutes an inherent limitation in our study; tissue heterogeneity potentially influenced measurement of gene expression levels \[[@pone.0117011.ref069], [@pone.0117011.ref070]\]. Nonetheless, we assessed gene expression as representative of systemic biological differences between BMS and AMS offspring to which multiple organs and tissues have contributed. Causality of identified variants cannot be determined: identified variants might be markers of genomic regions or loci in which causal variants lie and allelic heterogeneity cannot be ruled out, together necessitating much larger population studies than our unique but relatively small cohort study.

Strengths of our study are the unique genetically and phenotypically characterized offspring cohort discordant for maternal gestational metabolic fitness, the efficacious standardized currently performed metabolic operation as a tool to alter the intrauterine milieu and an exceptionally high follow-up rate enabled by the national health insurance system. The biliopancreatic bypass operation selectively increases steatorrhea, lowering maternal plasma free fatty acids, reducing fatty infiltration of metabolically active tissues, reducing lipid peroxidation and systemic lipotoxic inflammation altogether improving insulin action and glucose disposal approximating pre-obese levels. Although these durable effects were not replicated quantitatively or qualitatively by other current bariatric operations, they add critical insight into molecular mechanisms associated with the gene expression levels presented here.

Our results demonstrated influences of the intrauterine metabolic environment on associations between offspring genotype and gene expression levels. The lower prevalence of obesity and cardiometabolic risk observed in AMS offspring argues for implementation of maternal weight loss and improved metabolic fitness before pregnancy and provides potential mechanisms for physiological improvements through regulation of gene expression in offspring.
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###### Example of transcripts under multiple genetic constraints from the most represented transcripts.

Panel A, *STAT2* (NM_005419). Panel B, *IFI35* (NM_005533). Panel C, *DGKZ* (NM_003646).

(TIF)
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Click here for additional data file.

###### Mothers' characteristics.

(DOCX)

###### 

Click here for additional data file.

###### Gene expression levels for most significant SNP-by-maternal status interactions.

SNPs, regulated transcripts and genotype-specific gene expression levels are shown. Expression values (means) relative to common homozygotes from the BMS group.

(DOCX)

###### 

Click here for additional data file.

###### Most represented SNPs from the list of significant interactions.

(DOCX)

###### 

Click here for additional data file.

###### Functional clusters for transcripts with significant associations.

(DOCX)

###### 

Click here for additional data file.
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